Pre-donation BMI and preserved kidney volume can predict the cohort with unfavorable renal functional compensation at 1-year after kidney donation.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
08 02 2019
Historique:
received: 20 11 2018
accepted: 30 01 2019
entrez: 10 2 2019
pubmed: 10 2 2019
medline: 8 2 2020
Statut: epublish

Résumé

The magnitude of renal function recovery after kidney donation differs in donors with a heterogeneous background. Preoperative assessment of candidates with potentially unfavorable renal functional compensation is critical when baseline kidney function is marginal. We explored the significance of preserved kidney volume (PKV) and known preoperative risk factors for the prediction of unfavorable renal function compensation. We enrolled 101 living donors for whom a 1-mm sliced enhanced computed tomography scan was performed preoperatively and clinical data could be collected up to 1 year after donation. The donors whose estimated glomerular filtration rate (eGFR) at 1 year after donation was 70% or higher of baseline eGFR were assigned to the "favorable renal compensation" group and the others to the "unfavorable renal compensation" group. Age, sex, and preoperative serum uric acid level were not significant predictors for "unfavorable renal compensation." Multivariable logistic regression analysis revealed that body mass index (BMI) and body surface area (BSA)-adjusted PKV were independent preoperative risk factors for "unfavorable renal compensation" (adjusted odds ratio, 1.342 and 0.929, respectively). Hypertension and preoperative eGFR were not independent predictors when adjusted with BMI and BSA-adjusted PKV. Receiver operative characteristic analysis revealed that the predictive equation with the two independent predictors yielded a good accuracy to detect donor candidates with unfavorable renal functional compensation (area under the curve = 0.803), and the optimal cut-off values were identified as 23.4 kg/m BMI and BSA-adjusted PKV may be useful to select candidates with potentially unfavorable renal function compensation before kidney donation.

Sections du résumé

BACKGROUND
The magnitude of renal function recovery after kidney donation differs in donors with a heterogeneous background. Preoperative assessment of candidates with potentially unfavorable renal functional compensation is critical when baseline kidney function is marginal. We explored the significance of preserved kidney volume (PKV) and known preoperative risk factors for the prediction of unfavorable renal function compensation.
METHODS
We enrolled 101 living donors for whom a 1-mm sliced enhanced computed tomography scan was performed preoperatively and clinical data could be collected up to 1 year after donation. The donors whose estimated glomerular filtration rate (eGFR) at 1 year after donation was 70% or higher of baseline eGFR were assigned to the "favorable renal compensation" group and the others to the "unfavorable renal compensation" group.
RESULTS
Age, sex, and preoperative serum uric acid level were not significant predictors for "unfavorable renal compensation." Multivariable logistic regression analysis revealed that body mass index (BMI) and body surface area (BSA)-adjusted PKV were independent preoperative risk factors for "unfavorable renal compensation" (adjusted odds ratio, 1.342 and 0.929, respectively). Hypertension and preoperative eGFR were not independent predictors when adjusted with BMI and BSA-adjusted PKV. Receiver operative characteristic analysis revealed that the predictive equation with the two independent predictors yielded a good accuracy to detect donor candidates with unfavorable renal functional compensation (area under the curve = 0.803), and the optimal cut-off values were identified as 23.4 kg/m
CONCLUSIONS
BMI and BSA-adjusted PKV may be useful to select candidates with potentially unfavorable renal function compensation before kidney donation.

Identifiants

pubmed: 30736760
doi: 10.1186/s12882-019-1242-0
pii: 10.1186/s12882-019-1242-0
pmc: PMC6368798
doi:

Substances chimiques

Uric Acid 268B43MJ25
Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

46

Références

Am J Transplant. 2008 Oct;8(10):2077-85
pubmed: 18727700
Transplantation. 2015 Mar;99(3):555-9
pubmed: 25136845
Eur J Radiol. 2018 Feb;99:118-123
pubmed: 29362141
Kidney Int. 2014 Jul;86(1):162-7
pubmed: 24284516
N Engl J Med. 2009 Jan 29;360(5):459-69
pubmed: 19179315
Nutrition. 1989 Sep-Oct;5(5):303-11; discussion 312-3
pubmed: 2520314
J Clin Invest. 2015 Mar 2;125(3):1311-8
pubmed: 25689253
Kidney Int. 2010 Oct;78(7):686-92
pubmed: 20463656
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Transplant Proc. 2015 Nov;47(9):2700-2
pubmed: 26680075
Am J Kidney Dis. 2009 May;53(5):751-9
pubmed: 19339092
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Transplantation. 2016 Jun;100(6):1270-7
pubmed: 26356175
World J Surg Oncol. 2014 Mar 19;12:59
pubmed: 24641796
Am J Physiol Renal Physiol. 2015 Mar 15;308(6):F567-71
pubmed: 25568135
Clin Transplant. 2014 Jun;28(6):675-82
pubmed: 24654729
J Urol. 2010 Sep;184(3):1057-63
pubmed: 20643435
JAMA. 2014 Feb 12;311(6):579-86
pubmed: 24519297
Am J Transplant. 2013 Sep;13(9):2342-51
pubmed: 23865821
Transplantation. 2012 Feb 27;93(4):412-7
pubmed: 22217533
Nephrol Dial Transplant. 2012 Jan;27(1):41-50
pubmed: 22287701
J Clin Invest. 2015 Mar 2;125(3):972-4
pubmed: 25689262
Transplant Proc. 2015 Mar;47(2):290-4
pubmed: 25769562
N Engl J Med. 2016 Feb 4;374(5):411-21
pubmed: 26544982
BMJ. 2012 Mar 01;344:e1203
pubmed: 22381674
Int J Urol. 2013 Sep;20(9):931-4
pubmed: 23331616
Radiology. 2018 Jul;288(1):153-157
pubmed: 29558297
Clin Transplant. 2016 Sep;30(9):1028-35
pubmed: 27396944
Nephrol Dial Transplant. 2009 Dec;24(12):3732-8
pubmed: 19596742
Ann Intern Med. 1974 Oct;81(4):440-7
pubmed: 4416380
Nephrol Dial Transplant. 2012 Jan;27(1):443-7
pubmed: 21636826
Urology. 2017 Jun;104:115-121
pubmed: 28232178
Kidney Int. 2006 Nov;70(9):1636-41
pubmed: 16955108
Transplant Proc. 2017 Jun;49(5):1023-1026
pubmed: 28583519
Transplant Proc. 2018 May;50(4):1022-1024
pubmed: 29731060
J Am Soc Nephrol. 2015 Jun;26(6):1261-7
pubmed: 25525178

Auteurs

Kazunobu Shinoda (K)

Department of Urology, Keio University School of Medicine, Tokyo, 160-8582, Japan. kshino49@yahoo.co.jp.
Department of Nephrology, Toho University Faculty of Medicine, 7-5-23 Omorinishi Ota-ku, Tokyo, 143-0015, Japan. kshino49@yahoo.co.jp.

Shinya Morita (S)

Department of Urology, Keio University School of Medicine, Tokyo, 160-8582, Japan.

Hirotaka Akita (H)

Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo, 160-8582, Japan.

Satoshi Tamaki (S)

Department of Urology, Keio University School of Medicine, Tokyo, 160-8582, Japan.

Ryohei Takahashi (R)

Department of Urology, Keio University School of Medicine, Tokyo, 160-8582, Japan.

Hidaka Kono (H)

Department of Urology, Tokyo Dental College Ichikawa General Hospital, Chiba, 272-8513, Japan.

Hiroshi Asanuma (H)

Department of Urology, Keio University School of Medicine, Tokyo, 160-8582, Japan.

Eiji Kikuchi (E)

Department of Urology, Keio University School of Medicine, Tokyo, 160-8582, Japan.

Masahiro Jinzaki (M)

Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo, 160-8582, Japan.

Ken Nakagawa (K)

Department of Urology, Tokyo Dental College Ichikawa General Hospital, Chiba, 272-8513, Japan.

Mototsugu Oya (M)

Department of Urology, Keio University School of Medicine, Tokyo, 160-8582, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH